Want to join the conversation?
$CLX management maintained its previously provided outlook for FY16, wherein it anticipates sales growth of flat to up 1% and adjusted earnings in the range of $4.68-4.83 per share. On a currency-neutral basis, the company expects sales growth to be in the range of 3-4% for FY16.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.